DC
ROIV icon

Diametric Capital’s Roivant Sciences ROIV Stock Holding History

Diametric Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,921
Closed -$130K – 382
2025
Q1 		$130K Buy
+12,921
New +$140K 0.16% 153
2024
Q4 		– Sell
-26,950
Closed -$311K – 431
2024
Q3 		$311K Buy
26,950
+758
+3% +$8.63K 0.15% 205
2024
Q2 		$277K Sell
26,192
-5,731
-18% -$62.8K 0.15% 193
2024
Q1 		$336K Sell
31,923
-22,294
-41% -$240K 0.19% 140
2023
Q4 		$609K Buy
+54,217
New +$528K 0.37% 82

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Diametric Capital's ROIV Position: Q2 2025 in Review

Diametric Capital sold out of Roivant Sciences (ROIV) in Q2 2025, closing a stake of 12,921 shares — an estimated $130K sold.

Diametric Capital first reported a position in ROIV in Q4 2023 and held it in 5 quarters. The position peaked at $609K in Q4 2023. 337 funds tracked by Wall St. Rank hold ROIV as of Q2 2025.

  • Diametric Capital reported no remaining Roivant Sciences position as of Q2 2025 after selling out during the quarter.
  • Diametric Capital sold 12,921 Roivant Sciences shares in Q2 2025, an estimated $130K.
  • Diametric Capital first reported a position in Roivant Sciences in Q4 2023 and held it in 5 quarters.
  • Diametric Capital's Roivant Sciences position peaked at $609K in Q4 2023.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2025.

Based on Diametric Capital's 13F filing for Q2 2025, filed 13 Aug 2025.